Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations) Cheat Sheet
Cheat sheet: regulatory review for FINRA Series 161 candidates covering research reports, analyst conflicts, disclosures, communications, supervision, and high-yield exam traps.
This Cheat Sheet is independent exam-prep support for FINRA Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations). Use it to review the regulatory judgment expected of a supervisory analyst: identifying regulated research, applying conflict rules, checking disclosures, supervising communications, and spotting prohibited conduct.
Use the tables for a quick pre-exam check. Expand a topic’s notes for explanations, examples, and additional distinctions.
High-Yield Regulatory Map
| Area | Core idea | Series 161 exam focus |
|---|---|---|
| FINRA research rules | Broker-dealer rules for research analysts, research reports, conflicts, disclosures, and supervision | Equity research under Rule 2241; debt research under Rule 2242; analyst independence |
| FINRA communications rules | Standards for communications with the public | Retail vs institutional vs correspondence; fair and balanced content; approval and recordkeeping |
| SEC Regulation AC | Analyst certification rule | Required certifications in research reports and public appearances |
| Securities Act of 1933 | New issue registration, prospectuses, offering communications, liability | Research around offerings; misstatements; underwriting conflicts |
| Securities Exchange Act of 1934 | Secondary trading, antifraud, broker-dealer regulation, reporting, tender/proxy rules | Rule 10b-5, manipulation, insider trading, Reg FD, Reg M |
| Books and records | Required preservation of communications, approvals, certifications, and supervisory records | What must be retained and why |
| Supervision | Written supervisory procedures, principal review, escalation, annual testing | Who approves, who escalates, and what controls prevent violations |
Notes and examples
High-Yield Regulatory Map
| Area | What to know cold | Common exam trap |
|---|---|---|
| Research report status | Whether a written/electronic communication is research, sales material, correspondence, institutional communication, or something else | Assuming every market comment is a research report, or assuming no research rule applies because the audience is institutional |
| Supervisory analyst review | Approval focuses on fairness, balance, reasonable basis, disclosure, conflicts, and compliance with firm procedures | Treating approval as a guarantee that the recommendation will be profitable |
| Analyst independence | Research cannot be controlled by investment banking, issuers, or sales pressure | Letting investment banking “fact-check” conclusions, ratings, or price targets |
| Required disclosures | Firm, analyst, compensation, ownership, market-making/trading, ratings, price target, and other material conflicts | Relying on generic boilerplate when a specific conflict must be disclosed |
| Communications with the public | FINRA communication categories, approval standards, supervision, and content standards | Thinking institutional communications have no standards because they may not require the same pre-use approval |
| Regulation AC | Analyst certification that views are personal and compensation is not tied to the specific recommendation or views | Forgetting public appearances can trigger certification/disclosure issues |
| MNPI and insider trading | Materiality, nonpublic status, misuse, tipping, information barriers, restricted/watch lists | Publishing or trading after receiving selective issuer information |
| Offerings and distribution | Research around offerings, quiet/restricted periods where applicable, anti-conditioning concerns, Regulation M concepts | Treating research as separate from offering rules when it can condition the market |
| Supervision and records | WSPs, escalation, version control, approvals, substantiation, corrections, surveillance | Knowing the rule concept but missing the documentation obligation |
Core Definitions to Know Cold
| Term | Practical meaning | Exam trap |
|---|---|---|
| Supervisory analyst | Qualified supervisory person responsible for reviewing/approving research content under firm procedures | Not merely a senior analyst or editor |
| Research analyst | Associated person primarily responsible for preparing research content or whose name appears on the report | Includes named analysts; title alone is not decisive |
| Research report | Written or electronic communication with analysis of securities/issuers and enough information to support an investment decision | A short email, PDF, blog post, or portal note can qualify if it has analysis and a recommendation basis |
| Equity research report | Research report focused on equity securities of individual companies or industries | Broad market commentary may be excluded; issuer-specific analysis may not be |
| Debt research report | Research report focused on debt securities or debt issuers within the scope of debt research rules | Do not automatically apply every equity research rule to institutional debt research |
| Public appearance | Analyst communication in a seminar, webinar, interview, broadcast, podcast, conference, or similar forum | Not a written report, but still subject to disclosures and Regulation AC concepts |
| Subject company | Issuer that is the focus of the research | Conflicts are measured against this issuer |
| Investment banking services | Underwriting, acting as placement agent, merger/acquisition advisory, or similar capital-raising/advisory services | Commercial lending or ordinary trading is not automatically investment banking |
| Research analyst account | Account of the analyst, certain household members, or accounts controlled by the analyst | Personal trading restrictions cannot be avoided by using a related account |
| Institutional investor | Institutional recipient as defined under FINRA rules and firm procedures | Institutional status affects communication review and debt research treatment |
| Retail investor | Investor that is not an institutional investor | Retail distribution usually triggers stricter communications and disclosure expectations |
| Third-party research | Research prepared by someone other than the distributing member firm | Distribution can still create supervisory and disclosure responsibilities |
| Independent third-party research | Third-party research from a source sufficiently independent of the member and subject company | “Third-party” does not always mean “independent” |
Research Report Decision Path
flowchart TD
A[Communication created or distributed] --> B{Written or electronic?}
B -- No --> C{Analyst public appearance?}
C -- Yes --> D[Apply public appearance disclosures and Reg AC controls]
C -- No --> E[Apply general supervision and communications standards]
B -- Yes --> F{Issuer/security-specific analysis?}
F -- No --> G[Likely market/economic commentary; apply communications standards]
F -- Yes --> H{Enough information to support investment decision?}
H -- No --> I[May be sales commentary or institutional communication; supervise content]
H -- Yes --> J{Equity or debt?}
J -- Equity --> K[Apply FINRA equity research rules, disclosures, approvals]
J -- Debt --> L[Apply FINRA debt research rules; check retail vs institutional]
Research Report vs Non-Research Communication
| Communication | Usually research report? | Why |
|---|---|---|
| “Buy ABC; 12-month target $60 based on margin expansion” | Yes | Issuer-specific analysis and investment conclusion |
| Full initiation report on XYZ common stock | Yes | Classic equity research report |
| Credit note recommending purchase of ABC bonds | Usually yes | Debt issuer/security analysis |
| Broad market note: “Rates may remain volatile this quarter” | Usually no | Market/economic commentary, not issuer-specific |
| List of earnings dates with no analysis | Usually no | Factual/statistical information only |
| Technical analysis of a broad index | Usually no | Not individual issuer analysis |
| Individual account recommendation by a registered representative | Not necessarily research | May be suitability/best interest communication, not research report |
| Prospectus, proxy statement, or statutory offering document | Usually excluded from research report definition | Governed by offering/proxy rules |
| Internal draft not distributed to customers | Not a customer research report yet | Still subject to confidentiality and supervision |
| Social media post summarizing a rating change | Can be research or retail communication | Format does not avoid the rule |
FINRA Equity Research: Conflict Controls
| Conflict area | What the rules are trying to prevent | Supervisory analyst review point |
|---|---|---|
| Investment banking influence | Research used as a reward, inducement, or sales tool for investment banking business | Look for IB pressure, promised favorable coverage, or altered ratings |
| Prepublication review | Non-research personnel shaping research conclusions before publication | Confirm permitted factual/conflict review is controlled and documented |
| Analyst compensation | Analyst pay tied to specific investment banking transactions | Check compensation disclosures and committee documentation |
| Research budget | Budget decisions driven by specific banking deals | Ensure firm procedures separate research resource decisions from transaction rewards |
| Solicitation of banking business | Analyst participation in pitches, road shows, or promises of favorable research | Prohibited conduct; disclosure does not cure it |
| Personal trading | Analyst trading ahead of research or contrary to published views | Check restricted lists, preclearance, blackout periods, and exceptions |
| Selective disclosure | Giving favored clients, sales, trading, or bankers advance access to research conclusions | Verify distribution controls and timing |
| Retaliation | Punishing analysts for unfavorable coverage | Escalate evidence of pressure or retaliation |
| Issuer influence | Subject company editing conclusions, ratings, or targets | Issuer factual review must not become content approval |
Equity Research Disclosures Checklist
For issuer-specific equity research, verify the report includes clear, prominent, current disclosures where applicable.
| Disclosure item | What to check |
|---|---|
| Rating system | Meanings of ratings such as buy, hold, sell, outperform, market perform |
| Ratings distribution | Firmwide distribution of ratings and investment banking relationships by rating category, if required |
| Price chart | Historical price chart with rating/price target changes when required |
| Valuation method | Basis for price target or recommendation, including key assumptions |
| Risks | Material risks that could prevent the target or recommendation from working |
| Analyst financial interest | Analyst or household ownership/financial interest in the subject company |
| Firm ownership | Firm or affiliate beneficial ownership threshold disclosures, when applicable |
| Market making | Whether the firm makes a market in the subject security, when applicable |
| Investment banking role | Managed/co-managed offering or received investment banking compensation in the relevant lookback period |
| Expected banking compensation | Whether the firm expects or intends to seek investment banking compensation |
| Other compensation | Non-investment-banking compensation or other material business relationships, where required |
| Analyst compensation | Whether analyst compensation is tied to firm revenues or investment banking revenues, as applicable |
| Material conflicts | Any other known material conflict that could affect objectivity |
Debt Research: Retail vs Institutional Treatment
| Issue | Retail debt research | Institutional debt research |
|---|---|---|
| Audience | Retail investors or mixed distribution including retail | Eligible institutional investors only |
| Protection level | More similar to equity-style independence and disclosure controls | More flexible if institutional conditions and disclosures are satisfied |
| Sales/trading interaction | More restricted | May allow more interaction, subject to procedures and anti-fraud standards |
| Disclosures | Robust conflict disclosures expected | May use institutional conflict disclosures and notices |
| Opt-in/opt-out concept | Retail protections apply by default for retail recipients | Institutional recipients may have choices under firm procedures |
| Exam trap | Calling a debt note “institutional” does not make it exempt if sent to retail | Institutional debt research is not free from antifraud, supervision, or conflict rules |
SEC Regulation AC
| Requirement | Practical meaning |
|---|---|
| Analyst certification in research reports | Analyst certifies the views accurately reflect personal views |
| Compensation certification | Analyst certifies no part of compensation was, is, or will be directly or indirectly related to the specific recommendation or views, unless properly disclosed |
| Public appearances | Analyst public statements require certification controls and records |
| Applies alongside FINRA rules | Regulation AC does not replace FINRA research disclosures or conflict restrictions |
| False certification risk | A technically included certification is not enough if the process contradicts it |
Notes and examples
Regulation AC Exam Traps
| Trap | Correct approach |
|---|---|
| “The report has Regulation AC certification, so no FINRA disclosures are needed.” | Wrong. Reg AC certification and FINRA conflict disclosures are separate. |
| “Compensation can never include firmwide revenues.” | The issue is compensation tied to specific recommendations or views and required disclosure of relevant compensation factors. |
| “Public appearances are unregulated because they are oral.” | Wrong. Analyst public appearances require controls and disclosures. |
| “Certification fixes a misleading report.” | Wrong. Antifraud and communications standards still apply. |
Regulation AC Cheat Sheet
Regulation AC is a high-yield research analyst certification rule.
| Requirement | Exam meaning |
|---|---|
| Personal views certification | The analyst certifies that the views expressed accurately reflect the analyst’s personal views |
| Compensation certification | The analyst certifies that compensation was not, is not, and will not be directly or indirectly related to the specific recommendation or views |
| Research reports | Certification must be included clearly in covered research reports |
| Public appearances | Analyst public statements can create certification and disclosure obligations |
| Conflict with business pressure | If compensation or business influence is tied to a specific recommendation, the issue is not solved by wording alone; escalate |
Regulation AC Trap
If a scenario says the analyst changed a rating because investment banking requested it, the problem is not merely a missing disclosure. The issue is independence, anti-fraud risk, supervisory failure, and potentially a false certification.
FINRA Communications Classification
| Category | Audience test | Typical review approach | Series 161 issue |
|---|---|---|---|
| Retail communication | More than 25 retail investors within a 30-calendar-day period | Generally principal approval before first use, unless an exception applies | Research sent broadly to retail customers requires strict review |
| Correspondence | 25 or fewer retail investors within a 30-calendar-day period | Supervision and review under firm procedures | Personalized or limited distribution still cannot be misleading |
| Institutional communication | Institutional investors only | Supervision under firm procedures; not usually pre-use retail approval | If forwarded to retail, retail rules may be triggered |
| Internal communication | Within the firm only | Supervision, confidentiality, information barriers | Draft research can still create MNPI or conflict issues |
| Public appearance | Live or recorded analyst event | Disclosure and supervisory controls | Not a written report, but still regulated |
Notes and examples
FINRA Communications With the Public
Research reports often overlap with FINRA communication rules. The correct answer may require applying both research rules and general communication standards.
| Category | Basic idea | Approval/supervision focus |
|---|---|---|
| Retail communication | Written/electronic communication to more than 25 retail investors | Typically requires principal review/approval before use unless an exception applies |
| Correspondence | Written/electronic communication to 25 or fewer retail investors | Subject to supervision and review under firm procedures |
| Institutional communication | Written/electronic communication only to institutional investors | Subject to written procedures, training, and supervision; still cannot be misleading |
| Public appearance | Live or recorded public expression of views | Fairness, balance, disclosures, and analyst conduct matter |
| Internal communication | Within the firm | Still relevant for supervision, MNPI, information barriers, and records |
Universal Content Standards
Regardless of category, communications should be:
- fair and balanced;
- not false, exaggerated, unwarranted, promissory, or misleading;
- clear about risks and limitations;
- consistent with facts and context;
- appropriately sourced;
- free of misleading omissions;
- approved or supervised under firm procedures.
Communication Classification Traps
| Scenario | Better exam analysis |
|---|---|
| “It was sent only to institutions, so no rules apply.” | Institutional communications still require supervision and must not mislead |
| “It is only a tweet/post.” | Electronic and social media communications can be regulated communications |
| “It is only a draft.” | Drafts can create supervision, confidentiality, issuer review, and MNPI issues |
| “It is factual, so no approval is needed.” | Factual content can still be misleading by omission or context |
| “It is oral, so research rules do not matter.” | Public appearances and oral statements can trigger disclosures and anti-fraud duties |
Content Standards for All Communications
| Standard | Practical test |
|---|---|
| Fair and balanced | Does the communication present material risks, not just benefits? |
| No false or misleading statements | Are facts accurate, current, and sourced? |
| No exaggerated claims | Avoid “guaranteed,” “safe,” “certain,” or unsupported superlatives |
| Reasonable basis | Is there support for recommendations, ratings, and price targets? |
| Clear separation of fact and opinion | Are assumptions and judgments identified as such? |
| Balanced performance discussion | Past performance is not presented as predictive |
| Appropriate audience | Is the content suitable for the sophistication and status of recipients? |
| Required disclosures | Are conflicts visible and understandable, not buried? |
| No omitted material facts | Would missing information change the total mix for a reasonable investor? |
Approval and Review Matrix
| Item | Pre-use approval or control | Who is involved | Key record |
|---|---|---|---|
| Firm-created equity research report | Approval under research and communications procedures | Supervisory analyst/research principal; legal/compliance as needed | Final report, approvals, disclosures, certifications |
| Firm-created debt research report | Approval/review based on retail or institutional status | Qualified principal/supervisory personnel | Final report, audience classification, approvals |
| Third-party research distributed by firm | Review for reliability, conflicts, and misleading content | Supervisory principal; research/compliance | Due diligence, disclosures, distribution record |
| Independent third-party research | Modified review may apply if independence conditions are met | Supervisory principal/compliance | Independence basis and conflict disclosures |
| Retail communication | Principal approval before first use unless exception applies | Appropriately registered principal | Approved version and approval evidence |
| Institutional communication | Supervision under written procedures | Designated supervisor | Sampling/review logs, if applicable |
| Correspondence | Supervision under written procedures | Designated supervisor | Review evidence under firm procedures |
| Public appearance by analyst | Disclosure and supervisory controls | Analyst; supervisor; compliance | Appearance records and certifications |
Third-Party Research
| Question | Why it matters |
|---|---|
| Who prepared it? | Determines whether it is firm research, third-party research, or independent third-party research |
| Did the firm influence it? | Influence can create adoption/entanglement and greater responsibility |
| Is the source reliable? | Firm should not distribute research it knows or has reason to know is false, biased, or unreliable |
| Are conflicts disclosed? | Distribution may require disclosure of firm, source, or issuer conflicts |
| Is it issuer-paid? | Issuer-paid research is a major conflict and should not be treated as independent |
| Did the firm excerpt or highlight it? | Selective excerpts can make a balanced report misleading |
Public Appearances by Research Analysts
| Scenario | Required mindset |
|---|---|
| TV interview discussing a covered issuer | Treat as public appearance; disclose material conflicts and comply with Reg AC controls |
| Conference panel with institutional investors | Still public appearance if analyst gives views publicly or semi-publicly |
| Webinar for clients | Analyze audience and content; may also be retail or institutional communication |
| Podcast discussing ratings | Oral format does not avoid research analyst standards |
| Interactive social media Q&A | Can create public appearance and communications supervision issues |
| Analyst repeats unpublished rating change | Potential selective disclosure and firm policy violation |
Analyst Personal Trading Controls
| Control | Purpose |
|---|---|
| Preclearance | Prevents trading ahead of reports or while in possession of sensitive research information |
| Restricted/watch lists | Blocks trading during offerings, pending rating changes, or MNPI concerns |
| Blackout periods | Prevent trading around publication or changes in rating/target |
| Contrary-trade restrictions | Prevent analyst accounts from trading against published recommendations without permitted exception |
| IPO/private placement controls | Prevent improper preferential allocations or conflicts |
| Household/account monitoring | Captures indirect trading through related or controlled accounts |
| Exception documentation | Hardship or other exceptions must be justified, approved, and recorded |
Investment Banking and Research: Permitted vs Prohibited
| Activity | Usually permitted? | Exam reasoning |
|---|---|---|
| Analyst conducts independent due diligence on an issuer | Yes | Research needs factual basis |
| Analyst meets issuer management for factual verification | Yes, with controls | Issuer cannot dictate conclusions |
| Legal/compliance reviews draft for conflicts | Yes | Conflict control, not content pressure |
| Investment banking reviews draft to suggest a higher rating | No | Improper influence |
| Investment banking verifies factual information through controlled process | Limited | Must not become approval or pressure |
| Analyst participates in investment banking pitch | No | Solicitation conflict |
| Analyst promises favorable research to win mandate | No | Prohibited inducement |
| Analyst joins road show to market an offering | No | Research cannot be sales arm of banking |
| Sales asks analyst to delay downgrade to help inventory | No | Trading pressure undermines independence |
| Analyst speaks to investors after report is broadly released | Yes, with supervision | Avoid selective disclosure and inconsistent statements |
Material Nonpublic Information and Information Barriers
| Concept | Practical test |
|---|---|
| Material information | Would a reasonable investor consider it important, or would it alter the total mix of information? |
| Nonpublic information | Not broadly disseminated to the market with time for investors to absorb it |
| MNPI result | Do not trade, tip, or publish research using the information until cleared |
| Information barrier | Separates research, investment banking, trading, and other sensitive functions |
| Wall crossing | Controlled process for sharing MNPI with need-to-know personnel |
| Restricted list | Limits trading or research when MNPI or conflicts exist |
| Watch list | Confidential monitoring list for potential issues |
| Mosaic theory | Analysts may combine public and immaterial nonpublic information; not a license to use MNPI |
| Escalation | When in doubt, stop and escalate to legal/compliance before publishing or trading |
Regulation FD and Selective Disclosure
| Point | Exam-ready rule |
|---|---|
| Primary target | Issuers, not analysts |
| Covered recipients | Includes securities market professionals such as analysts and broker-dealers |
| Intentional selective disclosure | Issuer should make simultaneous public disclosure |
| Unintentional selective disclosure | Issuer should make prompt public disclosure |
| Analyst receiving MNPI | Analyst and firm must avoid trading, tipping, or publishing based on MNPI |
| Trap | “The issuer violated Reg FD, so the analyst can use it.” Wrong. MNPI restrictions still apply. |
Antifraud and Liability Framework
| Rule or concept | What it prohibits | Research relevance |
|---|---|---|
| Exchange Act Rule 10b-5 | Fraud, material misstatements, omissions, and deceptive devices in connection with securities transactions | Misleading research, omitted conflicts, manipulated recommendations |
| Securities Act liability | Material misstatements or omissions in offering materials | Research around offerings must avoid becoming misleading sales material |
| FINRA communications standards | False, exaggerated, promissory, or unbalanced communications | Applies even without private litigation |
| Manipulation rules | Artificial price activity, rumors, matched orders, wash trades | Research cannot be used to move prices deceptively |
| Tender offer antifraud rules | Trading or tipping on tender offer information | Heightened sensitivity to deal rumors and banker information |
| Proxy rules | False or misleading proxy solicitations | Research touching proxy contests must be carefully reviewed |
Regulation M and Offering-Related Research
| Concept | Why supervisory analysts care |
|---|---|
| Distribution participant restrictions | Firms involved in distributions may face limits on bidding for or purchasing covered securities |
| Stabilization and penalty bids | Offering-market activities are tightly controlled and disclosed |
| Research near offerings | Conflicts are heightened when the firm is an underwriter or expects compensation |
| Old quiet-period memorization | Be cautious with outdated fixed day-count rules; follow current FINRA/SEC rules and firm procedures |
| Exam trap | Disclosure may be required, but disclosure alone does not permit prohibited solicitation or manipulation |
Required Disclosures: What “Good” Looks Like
| Weak disclosure | Better disclosure approach |
|---|---|
| “We may have conflicts.” | Identify the actual conflict when required, such as investment banking compensation, market making, ownership, or analyst interest |
| “Target price is $50.” | Explain valuation method, time horizon, assumptions, and risks |
| “Outperform.” | Define rating meaning and benchmark or time horizon |
| “See website for important disclosures.” | Ensure required disclosures are clear, prominent, and accessible under the applicable rule |
| “Company is a client.” | Specify the type of services or compensation where required |
| “Analyst owns shares.” | Disclose analyst or household financial interest as required |
Supervisory Analyst Prepublication Checklist
Classify the communication
- Equity research, debt research, third-party research, retail communication, institutional communication, correspondence, or public appearance.
Identify the audience
- Retail, institutional, mixed, internal, or public.
Check independence
- No investment banking pressure, issuer control, sales/trading influence, or promised favorable coverage.
Verify content standards
- Fair, balanced, accurate, sourced, and not misleading.
Review recommendation support
- Rating, price target, valuation method, assumptions, and risks are reasonable and explained.
Confirm required disclosures
- Ownership, market making, compensation, banking role, analyst interest, rating distribution, valuation risks, and known material conflicts.
Confirm Regulation AC certification
- Analyst personal views and compensation certification included where required.
Review personal trading controls
- Analyst accounts, household accounts, blackout periods, and restricted lists checked.
Control non-research review
- Any issuer, banking, sales, or trading comments are permitted, documented, and not outcome-driven.
Approve and preserve records
- Maintain approval evidence, final version, disclosures, certifications, source support, and distribution details.
Handling Problems After Publication
| Problem discovered | Immediate response |
|---|---|
| Material factual error | Escalate, assess investor impact, correct or retract under firm procedures |
| Missing required conflict disclosure | Stop further distribution, escalate, issue corrected disclosure if required |
| Analyst had undisclosed financial interest | Escalate to compliance; review report, trading records, and supervisory failure |
| Report may be based on MNPI | Halt distribution, restrict trading, consult legal/compliance |
| Investment banking influenced rating | Escalate; review communications, approvals, compensation, and potential regulatory reporting |
| Selective early distribution | Identify recipients, stop leak, assess corrective broad distribution and records |
| Public appearance omitted conflicts | Document, correct where appropriate, and review analyst controls |
Books and Records Focus
| Record | Why it matters |
|---|---|
| Final research reports | Shows what was distributed |
| Drafts and approvals | Evidence of supervisory review and changes |
| Disclosure support | Shows basis for conflict disclosures |
| Regulation AC certifications | Required analyst certification evidence |
| Distribution lists | Determines retail/institutional treatment and selective disclosure issues |
| Personal trading records | Supports analyst account controls |
| Restricted/watch list records | Shows MNPI and conflict monitoring |
| Third-party research due diligence | Supports distribution decision |
| Public appearance records | Supports analyst disclosure and certification controls |
| Written supervisory procedures | Shows required supervisory system |
| Exception approvals | Demonstrates controlled deviations from normal policy |
Federal Securities Law Cheat Sheet
| Law or rule | High-yield supervisory analyst angle |
|---|---|
| Securities Act of 1933 | New issues, registration, prospectuses, offering communications, liability for material misstatements |
| Securities Exchange Act of 1934 | Broker-dealer regulation, trading markets, reporting companies, antifraud, manipulation |
| Investment Company Act of 1940 | Fund regulation; fund communications may be governed by product-specific rules |
| Investment Advisers Act of 1940 | Adviser fiduciary duties, conflicts, advertising; relevant when research overlaps advisory services |
| SEC Regulation AC | Analyst certifications in research and public appearances |
| SEC Regulation FD | Issuer selective disclosure to analysts and market professionals |
| SEC Regulation M | Trading restrictions during distributions |
| Exchange Act Rule 10b-5 | Antifraud rule most relevant to misleading research |
| Tender offer rules | Deal information is highly sensitive; no trading/tipping on tender offer MNPI |
| Proxy rules | Avoid false or misleading statements in proxy-related analysis |
Common Series 161 Traps
| Trap | Correct answer pattern |
|---|---|
| “If it is sent by email, it is correspondence, not research.” | It can be both a communication and a research report depending on content and audience. |
| “Institutional audience eliminates all disclosure requirements.” | Institutional treatment can modify review, but antifraud, supervision, and many conflict rules remain. |
| “Disclosure cures prohibited conduct.” | Some conduct is banned even if disclosed, such as promising favorable research for banking business. |
| “Only written reports require analyst controls.” | Public appearances and social media can trigger disclosures and Regulation AC controls. |
| “Issuer factual review means issuer approval.” | Issuer may verify facts under controls; issuer cannot approve conclusions. |
| “Investment banking can review for business impact.” | Improper. Banking influence over ratings, targets, or timing is a major violation. |
| “Debt research is the same as equity research.” | Debt rules have different retail/institutional structure and market-specific flexibility. |
| “Third-party research is not the firm’s responsibility.” | Distribution creates review, conflict, and anti-misleading obligations. |
| “A price target needs only a number.” | It needs basis, valuation method, assumptions, and risks. |
| “Analyst compensation cannot consider any firm performance.” | The key issue is linkage to specific recommendations/views or banking transactions and proper disclosure. |
| “MNPI can be used if it helps investors.” | No. Stop, restrict, and escalate. |
| “Old quiet-period day counts always control.” | Use current rules, question facts, and firm procedures. |
Notes and examples
Series 161 Cheat Sheet
Use this page as a fast regulatory review for the FINRA Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations), exam code Series 161. It is designed to help you organize the rules before moving into topic drills, mock exams, and detailed explanations.
This is independent companion practice support, not affiliated with FINRA. The goal is to sharpen exam judgment: classify the communication, identify conflicts, determine approval and disclosure requirements, and know when a supervisory analyst must stop, escalate, or refuse approval.
Scenario Drill Table
| Scenario | Best regulatory response |
|---|---|
| Banker asks analyst to raise rating before a secondary offering | Refuse, document/escalate; improper investment banking influence |
| Issuer CFO edits draft to remove risk language | Do not accept substantive pressure; factual corrections only under controls |
| Analyst wants to buy stock before initiating coverage with Buy rating | Likely prohibited or restricted; apply preclearance, blackout, and account rules |
| Institutional salesperson wants early copy for top clients | Do not selectively disclose unpublished research |
| Third-party report is issuer-paid but labeled independent | Treat as conflict; do not distribute as independent without proper review/disclosure |
| Analyst mentions a covered company on a podcast | Treat as public appearance; apply disclosures and certification controls |
| Research report omits that firm makes a market in the stock | Correct disclosure before publication; if published, escalate and remediate |
| Analyst receives nonpublic acquisition rumor from banker | Treat as potential MNPI; stop publication/trading and escalate |
| Report states “minimal risk” for distressed bonds | Likely misleading; must present balanced credit risks |
| Retail clients receive institutional debt note | Reclassify and apply retail protections or stop distribution |
Final Review Checklist
Before exam day, be able to answer these quickly:
- Is the item a research report, public appearance, communication, or something else?
- Is it equity research or debt research?
- Is the audience retail, institutional, or mixed?
- Which rule set applies: FINRA research rules, communications rules, Regulation AC, antifraud, or offering rules?
- Is the conduct prohibited, restricted with controls, or permitted with disclosure?
- What conflicts must be disclosed?
- Who must approve or supervise the communication?
- What records must be retained?
- What should the supervisory analyst do if a problem is discovered?
Notes and examples
Final Cheat Sheet Checklist
Before moving to a mock exam, confirm you can answer these without notes:
- What makes a communication a research report?
- Who can review research before publication, and for what purpose?
- What disclosures are commonly required in equity and debt research?
- Why is generic boilerplate often insufficient?
- What does Regulation AC require?
- What is the difference between retail communication, correspondence, and institutional communication?
- What makes information material and nonpublic?
- What should a supervisory analyst do after receiving possible MNPI?
- Why can research around offerings be restricted?
- When must a supervisory analyst refuse approval?
- What records support the review and approval process?
For the next step, move into Series 161 topic drills using an independent question bank with original practice questions and detailed explanations, then review every miss by identifying the rule trigger and the supervisory action the exam wanted.
Fast Definitions to Review
| Term | Exam-ready meaning |
|---|---|
| Supervisory analyst | A qualified principal-type reviewer who approves or supervises research report content under firm procedures and applicable rules |
| Research report | A written or electronic communication that includes analysis of a security, issuer, or industry and provides information reasonably sufficient for an investment decision |
| Research analyst | A person primarily responsible for preparing the substance of a research report or whose name appears on the report |
| Subject company / issuer | The company or issuer discussed in the research |
| Retail communication | A written or electronic communication made available to more than 25 retail investors within the relevant period under FINRA communication rules |
| Correspondence | Written or electronic communication to 25 or fewer retail investors within the relevant period |
| Institutional communication | Written or electronic communication distributed only to institutional investors |
| Public appearance | Analyst participation in seminars, forums, media, interviews, webcasts, or similar appearances where views are expressed publicly |
| MNPI | Material nonpublic information: information a reasonable investor would consider important and that has not been broadly disseminated |
| Information barrier | Policies and controls designed to prevent improper flow of MNPI or influence between business units |
| Restricted list | A control list that typically limits trading, research, or communications in securities where conflicts or MNPI risks exist |
| Watch list | A confidential surveillance tool used by compliance to monitor securities, employees, or activity with heightened risk |
| Investment banking services | Underwriting, advisory, M&A, placement, or similar capital markets services that can create research conflicts |
The Core Exam Decision Sequence
When a question describes a communication, move in this order:
Classify the communication.
Is it research, retail communication, correspondence, institutional communication, internal communication, public appearance, or offering-related material?Identify the audience.
Retail and institutional treatment can differ, but content must still be fair, balanced, and not misleading.Identify the security and issuer.
Equity research, debt research, investment company material, options-related material, and offering material may trigger different overlays.Find the conflict.
Look for investment banking relationships, analyst compensation, firm ownership, analyst/household holdings, market making, principal trading, issuer review, or pressure from sales/trading.Apply approval and disclosure rules.
Ask: Who must approve? What must be disclosed? What must be removed? What must be documented?Check MNPI and anti-fraud risk.
If information is material and nonpublic, the answer usually involves stopping, escalating, restricting, or contacting compliance—not publishing quickly.Select the most supervisory answer.
On Series 161 scenarios, the correct answer often favors documented escalation, firm procedures, disclosure, and independent review over speed or business convenience.
Research Report Review: Supervisory Analyst Checklist
A supervisory analyst should not review only grammar or formatting. The exam tests whether the report is suitable for publication under regulatory standards.
| Review area | What to verify |
|---|---|
| Investment thesis | Clear, supported, and not exaggerated |
| Factual accuracy | Facts are checked against reliable sources; no cherry-picked data |
| Reasonable basis | Recommendation, rating, and price target are supported by analysis |
| Balance | Benefits and risks are presented fairly |
| Risks | Material risks are not buried or softened |
| Valuation support | Price target methodology, assumptions, and limitations are explained |
| Disclosures | Firm, analyst, compensation, ownership, market activity, and other conflicts are included as required |
| Independence | No improper influence from investment banking, issuer, sales, or trading |
| Source of information | Third-party data, issuer information, and estimates are identified where appropriate |
| Selective information | No MNPI is used or disseminated |
| Audience | Retail/institutional status and distribution channel are appropriate |
| Version control | Final approved version matches what is distributed |
| Corrections | Material errors are escalated and corrected under firm procedures |
| Records | Approval, support, disclosures, and communications are retained under firm policy |
Notes and examples
When a Supervisory Analyst Should Not Approve
Do not approve, or escalate before approval, when:
- The recommendation is unsupported by the analysis.
- The report includes selective issuer information that may be MNPI.
- Required conflicts are omitted or hidden.
- Investment banking or the issuer influenced conclusions, rating, or price target.
- Risks are materially understated.
- The report implies certainty, guarantees, or unrealistic performance.
- Data is stale, inconsistent, or not reasonably sourced.
- A price target lacks methodology or risk discussion.
- A correction is needed but the business wants to delay it.
- The firm is subject to an offering, restricted list, or other control that may limit publication.
Research Independence and Conflicts
Research rules focus heavily on preventing business interests from distorting research.
| Conflict source | Regulatory concern | Proper supervisory response |
|---|---|---|
| Investment banking | Pressure for favorable ratings, timing, or coverage | Keep research independent; route permitted factual review through compliance/legal |
| Issuer management | Attempts to influence conclusions before publication | Permit only limited factual review when allowed by procedure; remove ratings, price targets, and conclusions from issuer review drafts |
| Sales/trading | Pressure to support inventory, trading positions, or customer flows | Ensure research is based on analysis, not desk objectives |
| Analyst compensation | Compensation tied to specific transactions or recommendations | Review compensation disclosures and firm procedures |
| Analyst personal holdings | Analyst or household interest may bias views | Apply personal trading rules and disclose where required |
| Firm ownership or market activity | Firm position, market making, principal trading, or ownership creates conflict | Include required disclosures and consider restrictions |
| Investment banking compensation | Recent, expected, or sought compensation can bias research | Disclose and monitor for improper influence |
| Retaliation | Analyst punished for negative or independent research | Escalate; rules prohibit retaliation or threats for unfavorable research |
Notes and examples
Prepublication Review: What Is Usually Tested
| Reviewer | What may be acceptable | What is dangerous |
|---|---|---|
| Legal/compliance | Review for rule compliance, disclosures, conflicts, and factual/legal issues | Turning compliance review into business approval of the investment view |
| Investment banking | Generally not allowed to review or approve research content; limited interactions must follow procedures | Reviewing ratings, price targets, summaries, or conclusions |
| Subject company | Limited factual verification under controlled procedures | Seeing recommendations, ratings, price targets, or language that lets the issuer influence the opinion |
| Sales/trading | Market color may be relevant under procedures, especially in debt contexts | Desk pressure to change the rating, timing, or tone |
| Supervisory analyst | Independent review and approval under firm procedures | Rubber-stamping a report because a senior banker or issuer wants it released |
FINRA Research Rules: Equity and Debt Themes
Series 161 candidates should know the major differences between equity and debt research regulation, while recognizing the shared policy goal: objective research and conflict control.
| Theme | Equity research | Debt research |
|---|---|---|
| Core concern | Analyst independence from investment banking and issuer pressure | Conflicts involving trading, principal positions, institutional clients, and issuer relationships |
| Retail protection | Strong disclosure, approval, and conflict-management expectations | Retail debt research receives significant protections |
| Institutional treatment | Institutional audience does not erase anti-fraud duties | Institutional debt research may have reduced requirements in specific circumstances, but still must not be misleading |
| Trading desk interaction | Heavily controlled to prevent influence | More interaction may be allowed due to debt market structure, but influence and conflicts must be managed |
| Disclosure focus | Ratings, price targets, ownership, investment banking compensation, market making, analyst interests | Conflicts from trading, principal activity, compensation, issuer relationships, and other material interests |
Required Disclosure Concepts
Do not memorize disclosures as disconnected phrases. Ask: Would this fact reasonably help the reader evaluate bias?
| Disclosure concept | Why it matters |
|---|---|
| Analyst or household financial interest | Personal interest can bias the recommendation |
| Firm or affiliate ownership | Firm economic exposure can bias research |
| Investment banking compensation | Recent, expected, or sought compensation can influence research |
| Managed or co-managed offering | Underwriting role creates a major conflict |
| Market making / principal activity | Firm trading role may conflict with published opinion |
| Analyst compensation from issuer | Direct issuer compensation is a serious conflict |
| Rating system | Readers need to know what “buy,” “hold,” “sell,” or equivalent terms mean |
| Ratings distribution | Shows how ratings are distributed across the firm’s coverage universe |
| Price target methodology | Readers need the basis, assumptions, and risks behind the target |
| Other material conflicts | Catch-all: if material and known, disclose or escalate |
Notes and examples
Price Target Trap
A price target is not just a number. A proper research report should support it with:
- valuation method or analytical basis;
- important assumptions;
- time horizon where applicable;
- key risks that could prevent achievement;
- consistency with the rating and thesis.
A common wrong answer is to approve a report because the analyst is “experienced.” Experience does not replace documentation, reasonable basis, and disclosure.
MNPI, Insider Trading, and Information Barriers
When a question includes confidential earnings, merger talks, offering plans, rating changes, unpublished research, or issuer selective disclosure, immediately test for MNPI.
MNPI Decision Rules
| Question | If yes |
|---|---|
| Would a reasonable investor consider the information important? | Treat it as potentially material |
| Has it been broadly disseminated to the market? | If no, treat it as nonpublic |
| Did the firm receive it through a confidential or improper channel? | Escalate to compliance/legal |
| Is the firm, analyst, or customer about to trade or publish? | Stop and follow restriction procedures |
| Is there a restricted/watch list implication? | Follow firm controls before action |
Notes and examples
Correct Supervisory Response to MNPI Risk
The safest exam answer usually includes:
- Stop publication, trading, or dissemination.
- Escalate to compliance/legal.
- Determine whether the information is material and nonpublic.
- Apply restricted list, watch list, or information barrier procedures.
- Document the review and decision.
- Resume only if authorized under firm procedures.
Regulation FD Concept
Regulation FD focuses on selective disclosure by issuers. For Series 161 purposes, the key practical point is:
If an analyst receives material nonpublic issuer information selectively, the analyst should not trade on it, publish it, or selectively pass it along. Escalate under firm procedures.
Do not assume an analyst can “solve” selective disclosure by quickly publishing a report.
Anti-Fraud Rules: The Exam Lens
Anti-fraud analysis is broader than outright lies.
| Problem | Why it matters |
|---|---|
| False statement | Direct misrepresentation |
| Misleading omission | Leaving out a material fact can make true statements misleading |
| Half-truth | Accurate fact presented without necessary context |
| Cherry-picked data | Selective facts can distort the investment picture |
| Unsupported projection | Forecast appears more certain than the analysis supports |
| Hidden conflict | Reader cannot evaluate bias |
| Stale information | Outdated data can mislead if presented as current |
| Unclear assumptions | Readers cannot evaluate reasonableness |
A supervisory analyst should ask: Would the communication mislead a reasonable investor, even if each sentence is literally true?
Research Around Offerings and Distributions
Offering-related questions often combine research rules, Securities Act concepts, Regulation M, and conflicts.
| Concept | Exam-ready review |
|---|---|
| Gun-jumping / conditioning the market | Research can be problematic if it acts as an offer or conditions demand during an offering process |
| Research safe harbors | Certain regular research may be permitted if conditions are met; do not assume all research during an offering is allowed |
| Participating underwriter conflict | A firm involved in an offering has heightened conflict and distribution concerns |
| Restricted periods | Where applicable, research or trading may be limited by firm procedures and regulatory restrictions |
| Regulation M | Designed to prevent distribution participants from manipulating the market during a securities distribution |
| Tender offers | Heightened anti-fraud, insider trading, and equal-treatment concerns may apply |
| Post-offering research | Timing, independence, and disclosure controls remain important |
Notes and examples
Offering Scenario Trap
If a banker wants research issued to “support the deal,” the correct answer is not to add a disclosure and publish. The supervisory issue is improper influence and potential offering-related misuse of research.
Supervision, WSPs, and Records
Series 161 questions frequently test whether the firm has reasonable supervisory procedures and whether the supervisory analyst follows them.
| Supervisory area | What procedures should cover |
|---|---|
| Research creation | Analyst responsibilities, support, source review, and reasonable basis |
| Approval | Who approves, when approval is needed, and what changes require reapproval |
| Conflicts | Identification, disclosure, mitigation, and escalation |
| Information barriers | Separation of research, investment banking, sales/trading, and other sensitive areas |
| Personal trading | Analyst and covered-person restrictions, preclearance, blackout/restricted periods where applicable |
| Issuer review | Limited factual review procedures and required removal of conclusions or targets |
| Public appearances | Approval, monitoring, disclosures, and certification controls |
| Corrections | How material errors are corrected and communicated |
| Records | Drafts, approvals, substantiation, disclosures, certifications, distribution lists, and complaints |
| Training | Analyst and supervisor education on research rules and firm policies |
Notes and examples
Supervisory Analyst Duty vs. Business Pressure
If a question presents pressure from a senior producer, banker, issuer, or major client, choose the answer that preserves:
- independent judgment;
- required disclosure;
- compliance escalation;
- investor protection;
- accurate records;
- fair and balanced communication.
Common Candidate Mistakes
| Mistake | Better approach |
|---|---|
| Memorizing rule names but not applying them | Practice scenarios: classify, approve, disclose, escalate |
| Treating disclosure as a cure-all | Some conduct is prohibited even if disclosed |
| Ignoring omissions | A technically true statement can still mislead |
| Forgetting institutional communications standards | Institutional does not mean unregulated |
| Overlooking public appearances | Analyst comments in media or live events can trigger obligations |
| Allowing issuer review of conclusions | Factual verification is different from influence |
| Missing analyst household conflicts | Personal and household interests can require controls/disclosure |
| Confusing watch list and restricted list | Watch lists are often surveillance tools; restricted lists impose controls |
| Approving unsupported price targets | Require methodology, assumptions, and risks |
| Ignoring version control | The distributed version must match the approved version |
| Choosing the “business friendly” answer | The exam often favors documented supervisory action |
Rapid-Fire “If You See This, Think That”
| If the question says… | Think… |
|---|---|
| “Investment banking asked the analyst to change the rating” | Independence violation; escalate |
| “Issuer wants to review the draft” | Limited factual review only under procedures |
| “Analyst learned earnings before public release” | MNPI; stop and escalate |
| “Report has a buy rating but no risks” | Not fair and balanced |
| “Price target with no methodology” | Unsupported; do not approve |
| “Only sent to institutions” | Still subject to supervision and anti-fraud standards |
| “Compensation tied to a specific deal” | Regulation AC and conflict problem |
| “Firm recently underwrote the issuer” | Disclosure and conflict controls |
| “Analyst appears on TV” | Public appearance disclosures/certification issues |
| “Research issued during an offering” | Offering restrictions, conflicts, safe harbor analysis |
| “Sales desk wants favorable research to move inventory” | Improper influence/trading conflict |
| “Correction would embarrass the firm” | Correct material errors; document |
Mini Review: Best Answer Style
Series 161 answer choices often differ by supervisory strength. Prefer answers that say:
- “Escalate to compliance/legal before publication.”
- “Do not approve until required disclosures are included.”
- “Follow written supervisory procedures.”
- “Remove rating, price target, and conclusions before issuer factual review.”
- “Document the review and basis for approval.”
- “Restrict trading or publication pending MNPI analysis.”
- “Ensure the communication is fair, balanced, and not misleading.”
Be cautious with answers that say:
- “Publish because the information came from a reliable source.”
- “Approve because the audience is institutional.”
- “Add a generic disclosure and proceed.”
- “Let investment banking review for accuracy.”
- “Delay correction to avoid market reaction.”
- “Rely on the analyst’s reputation.”